Skinner, Pamela J
- University of Minnesota · Microbiology & Immunology (NIH department code)
- University of Minnesota (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #6,066
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Microbiology & Immunology
NIH Funding · FY2023
Linked Award Amount
$1.5M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#6,066
By linked amount among FY2023 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Skinner, Pamela J as a PI. Multi-PI records show the full award amount for context.
- 1R01DK133907-01R01Contact PITargeting HIV-specific CAR T cells to the gut for the durable remission of HIVUniversity of Minnesota · Microbiology & Immunology (NIH department code)$743.7Kaward amount
- 5R01AI143380-05R01Contact PITargeting virus-specific CAR T cells to lymphoid follicles to achieve durable HIV suppression$714.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Skinner, Pamela J as a PI.
FY2023 award administered by University of Minnesota (MN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardUniversity of Minnesota
- 2019$500K Cumulative Funding
- 2020$1M Cumulative Funding
- 2020Entered Top 50% NationallyRanked #5393
- 2020R01 Grant Holder
- 2021$2M Cumulative Funding